Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Spitler

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1974
Letter: The use of the cell migration inhibition testL E Spitler
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
Immunotoxin therapy of malignant melanomaL E Spitler
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Monoclonal antibodies in the treatment of malignant melanomaL E Spitler
Archives of Internal Medicine|January 1, 1980
Zoster immune globulinL E Spitler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Adjuvant therapy of melanoma: at what cost?L E Spitler
The American Journal of Medicine|July 1, 1979
Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patientsL E Spitler
California Medicine|February 1, 1973
Clinical uses of transfer factorL E Spitler
Journal of Experimental Pathology|January 1, 1987
Clinical trials of transfer factor in malignancyL E Spitler, L Miller
The New England Journal of Medicine|November 13, 1980
A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanomaL E Spitler, R Sagebiel
Clinical and Experimental Immunology|July 1, 1983
Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activityC F Scott, L E Spitler
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1974
Letter: The use of the cell migration inhibition testL E Spitler
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
Immunotoxin therapy of malignant melanomaL E Spitler
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Monoclonal antibodies in the treatment of malignant melanomaL E Spitler
Archives of Internal Medicine|January 1, 1980
Zoster immune globulinL E Spitler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Adjuvant therapy of melanoma: at what cost?L E Spitler
The American Journal of Medicine|July 1, 1979
Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patientsL E Spitler
California Medicine|February 1, 1973
Clinical uses of transfer factorL E Spitler
Journal of Experimental Pathology|January 1, 1987
Clinical trials of transfer factor in malignancyL E Spitler, L Miller
The New England Journal of Medicine|November 13, 1980
A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanomaL E Spitler, R Sagebiel
Clinical and Experimental Immunology|July 1, 1983
Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activityC F Scott, L E Spitler
Pageof 9